Target intelligence / Profile preview

No direct human or bacterial molecular target

Molecular classification
Other
01

Overview

The designation "No direct human or bacterial molecular target" refers to therapeutic agents that achieve clinical efficacy through physical or chemical mechanisms rather than by binding to specific biological macromolecules such as receptors or enzymes (StatPearls, 2023). Common examples include antacids like magnesium hydroxide, which neutralize gastric acid through a direct chemical reaction, and osmotic laxatives like polyethylene glycol, which increase stool water content via osmotic pressure (NIH, 2022). Additionally, agents such as activated charcoal function through the physical process of adsorption to trap toxins within the gastrointestinal tract (StatPearls, 2023). Because these substances do not rely on specific molecular recognition, their pharmacodynamics are governed by their bulk properties and chemical reactivity within specific physiological compartments. This classification is essential for distinguishing drugs with systemic molecular targets from those that act through non-specific, often localized, interactions (PubMed, 2021).

Other names
Non-molecular mechanism of actionPhysicochemical mechanismNon-specific therapeutic agent
02

Mechanism of action

Physical or chemical interaction including neutralization of acid, osmotic water retention, adsorption of molecules, or alteration of surface tension.

03

Biological functions

Acid-base neutralizationOsmosisAdsorptionSurfactant activity
04

Disease associations

DyspepsiaConstipationPoisoningFlatulence
05

Safety considerations

Electrolyte imbalanceDehydrationInterference with drug absorption
06

Interacting drugs

Aluminum hydroxide

5 more in the full profile.

Beyond the preview

Go deeper on No direct human or bacterial molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No direct human or bacterial molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call